@article{c02f9d796048448cab7d36e0a6aa2ffd,
title = "Comparison of Alicyclobacillus acidocaldarius o-Succinylbenzoate Synthase to Its Promiscuous N-Succinylamino Acid Racemase/ o-Succinylbenzoate Synthase Relatives",
abstract = " Studying the evolution of catalytically promiscuous enzymes like those from the N-succinylamino acid racemase/o-succinylbenzoate synthase (NSAR/OSBS) subfamily can reveal mechanisms by which new functions evolve. Some enzymes in this subfamily have only OSBS activity, while others catalyze OSBS and NSAR reactions. We characterized several NSAR/OSBS subfamily enzymes as a step toward determining the structural basis for evolving NSAR activity. Three enzymes were promiscuous, like most other characterized NSAR/OSBS subfamily enzymes. However, Alicyclobacillus acidocaldarius OSBS (AaOSBS) efficiently catalyzes OSBS activity but lacks detectable NSAR activity. Competitive inhibition and molecular modeling show that AaOSBS binds N-succinylphenylglycine with moderate affinity in a site that overlaps its normal substrate. On the basis of possible steric conflicts identified by molecular modeling and sequence conservation within the NSAR/OSBS subfamily, we identified one mutation, Y299I, that increased NSAR activity from undetectable to 1.2 × 10 2 M -1 s -1 without affecting OSBS activity. This mutation does not appear to affect binding affinity but instead affects k cat , by reorienting the substrate or modifying conformational changes to allow both catalytic lysines to access the proton that is moved during the reaction. This is the first site known to affect reaction specificity in the NSAR/OSBS subfamily. However, this gain of activity was obliterated by a second mutation, M18F. Epistatic interference by M18F was unexpected because a phenylalanine at this position is important in another NSAR/OSBS enzyme. Together, modest NSAR activity of Y299I AaOSBS and epistasis between sites 18 and 299 indicate that additional sites influenced the evolution of NSAR reaction specificity in the NSAR/OSBS subfamily.",
author = "Denis Odokonyero and McMillan, {Andrew W.} and Ramagopal, {Udupi A.} and Rafael Toro and Truong, {Dat P.} and Mingzhao Zhu and Lopez, {Mariana S.} and Belema Somiari and Meghann Herman and Asma Aziz and Bonanno, {Jeffrey B.} and Hull, {Kenneth G.} and Burley, {Stephen K.} and Daniel Romo and Almo, {Steven C.} and Glasner, {Margaret E.}",
note = "Funding Information: ∇R.T.: Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226. Author Contributions D.O. and A.W.M contributed equally to this work. Funding This work was funded by National Science Foundation CAREER Award 1253975 to M.E.G. The NYSGXRC was supported by National Institutes of Health (NIH) Grant U54 GM074945 (Principal Investigator, S. K. Burley). The NYSGRC is supported by NIH Grant U54 GM094662 (Principal Investigator, S.C.A.). The Center for Synchrotron Biosciences, where diffraction data were collected, was supported by Grant P30-EB-009998 from the National Institute of Biomedical Imaging and Bioengineering. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886. Synthetic chemistry performed at the Natural Products LINCHPIN Laboratory at Texas A&M University was supported by the Department of Chemistry, College of Science, and Office of the Vice President of Research and was continued at the CPRIT Synthesis and Drug Lead Discovery Laboratory at Baylor University supported by the College of Arts and Sciences and Baylor University. Notes The authors declare no competing financial interest. Publisher Copyright: Copyright {\textcopyright} 2018 American Chemical Society.",
year = "2018",
month = jul,
day = "3",
doi = "10.1021/acs.biochem.8b00088",
language = "English (US)",
volume = "57",
pages = "3676--3689",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "26",
}